What is the significance of diagnosis in Klinefelter’s Syndrome?

  • Research type

    Research Study

  • Full title

    ’A Common Condition: A Rare Diagnosis?’ What is the significance of diagnosis in Klinefelter’s Syndrome (47,XXY)?

  • IRAS ID

    172427

  • Contact name

    Jennifer Faithfull-Lloyd

  • Contact email

    jfaithfull-lloyd@bournemouth.ac.uk

  • Sponsor organisation

    Bournemouth University

  • Duration of Study in the UK

    3 years, 2 months, 2 days

  • Research summary

    What is the significance of diagnosis in Klinefelter’s syndrome?

    Klinefelter’s Syndrome is a sporadic, non-inherited genetic condition in males where there is the presence of an additional X chromosome. Although not well known, Klinefelter’s Syndrome is relatively common with an estimated incidence of approximately 1/650 males, compared to 1/250 incidence of autism in males and females. Few males are diagnosed, with only an estimated one quarter receiving a diagnosis and approximately 4-10% diagnosed before puberty.

    Klinefelter’s Syndrome is associated with a significant number of increased health risks which cause a reduction in life expectancy of approximately 2-6 years. Although IQ is usually unaffected, a complex array of neurodevelopmental, learning and educational difficulties contribute to a frequently reported pattern of under achievement. Furthermore, there are increased risks of a constellation of mental health conditions (e.g. schizophrenia and depression).

    Low diagnosis rates are attributed in the literature to two factors: low awareness among general practitioners and variability in presentation of the syndrome making diagnosis difficult or incorrect. Although this is universally reported, there is, to date, a paucity of evidence to explore the veracity of these claims. This research will examine if there is any evidence for these assertions by exploring perceptions of diagnosis from three different groups with different perspectives using qualitative interviews and questionnaires. These groups are: (a) affected individuals and their families (b) clinical specialists and (c) general practitioners. Interviews will last 60-120 minutes for Group (a) and 30-60 minutes for specialists and GPs depending on the time available. For Group (a) interviews will typically be conducted at home or mutually agreed meeting place and for Groups (b) and (c) at their place of work. This will provided much needed qualitative data about why diagnosis rates are low and the impact this has on affected individuals and their families.

  • REC name

    South West - Cornwall & Plymouth Research Ethics Committee

  • REC reference

    16/SW/0001

  • Date of REC Opinion

    12 Apr 2016

  • REC opinion

    Further Information Favourable Opinion